Ind-Swift Laboratories Limited
Related Stocks
About
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.
Price Range
52 Week
Low
87.15
High
343.50
Intraday
Low
316.90
High
343.50
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
Peer Comparison
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|
| 1 | Ind-Swift Laboratories Limited | 339.80 | +8.52% | 50.89 | 6.69 | 2,963 | 343.50 | 87.15 |
| 2 | Aarti Drugs Limited | 412.55 | +0.54% | 19.70 | 20.93 | 3,768 | 534.55 | 318.95 |
| 3 | Aarti Pharmalabs Limited | 867.75 | +0.60% | 36.95 | 23.50 | 7,863 | 946.10 | 585.00 |
| 4 | Abbott India Limited | 26,605.00 | -1.10% | 35.03 | 759.88 | 56,566 | 33,495.00 | 25,150.00 |
| 5 | ANLON HEALTHCARE LIMITED | 14.64 | +0.48% | 21.46 | 0.68 | 775 | 17.27 | 9.08 |
| 6 | Ajanta Pharma Limited | 3,719.60 | -0.02% | 40.95 | 90.83 | 46,484 | 3,796.00 | 2,329.90 |
| 7 | AKUMS DRUGS AND PHARMA L | 748.90 | +0.66% | 39.29 | 19.05 | 11,466 | 775.00 | 409.30 |
| 8 | Alivus Life Sciences Limited | 1,403.70 | +0.67% | 28.53 | 49.03 | 17,172 | 1,418.00 | 819.00 |
| 9 | Alkem Laboratories Limited | 5,463.50 | +1.68% | 30.29 | 180.45 | 65,318 | 5,933.50 | 5,075.00 |
| 10 | Amrutanjan Health Care Limited | 494.00 | +0.44% | 26.31 | 18.67 | 1,423 | 790.95 | 482.80 |
| 11 | Alembic Pharmaceuticals Limited | 825.95 | +0.38% | 23.40 | 35.27 | 16,210 | 1,002.00 | 635.80 |
| 12 | AstraZeneca Pharma India Limited | 7,654.00 | +0.09% | 112.93 | 67.85 | 19,155 | 9,849.50 | 7,551.50 |
| 13 | Aurobindo Pharma Limited | 1,635.50 | +0.54% | 25.55 | 64.00 | 94,950 | 1,682.40 | 1,016.10 |
| Median: 13 Co. | 867.75 | 0.54% | 30.29 | 35.27 | 16,210 | 1,002.00 | 635.80 |